Danish drugmaker Novo Nordisk plans to invest 8.5 billion Danish kroner (about €1.14 billion) to establish a new production facility in Odense, Denmark.
Italian drugmaker Newron Pharmaceuticals and EA Pharma, a subsidiary of Japan’s Eisai, today have entered into a license agreement to develop, manufacture and...
An Attractive and Highly Sought-after Business Location
The life sciences sector, encompassing biotechnology, pharmaceuticals and medical technology, is developing...
The Italian Olon Group, a leading international supplier of active pharmaceutical ingredients (APIs), presents the 2023 Corporate Sustainability Report and confirms the...
Ineos and its partners Harbour Energy and Nordsøfonden have taken the final investment decision (FID) into the first commercial phase ‘Greensand Future’ with storage...
French biotechnology company Samabriva has opened a new 1,400 m2 biomanufacturing facility in Liege, Belgium. The multi-million Euros investment is designed to provide...
In a move to expand its global biomanufacturing network, US biopharma Amgen is planning to invest $1 billion to build a second drug substance manufacturing facility at...
